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DNA Cytophotometric Findings in Pheochromocytoma
Barbara-Christina Padberg,* Esther Garbe,* Like Achilles,* Henning Dralle,*
Max Bressel,* and Soren Schroder*

Fifty adrenalectomy specimens containing normal (n = 3), hyperplastic (n =4), or neoplastic (n =
43) medullary tissue were subjected lo quantitative measurements of DNA conlent. Ofthe 43
pheochromocytomas, 16 were neoplasms inherited in the setting of multiple endocrine neoplasia type
2A. Five of 27 sporadic pheochromocytomas followed a malignant clinical course. Follow-up data
were available in 25 patients. In normal medulla and adrenomedullary hyperplasia, eilher diploid or
euploidDNA distributions were found. In contrast, 87% (33 of 38) of the benign and allfivemaUgnant
pheochromocytomas exhibited nondiploid or aneuploid DNA histograms. No differences in DNA
content existed between sporadic and hereditary tumors. In contrast to earlier reports, in this study
DNA cytophotometry was nol suitable to discriminate benign from malignant adrenomedullary
tumors. In addition, DNA measurements appeared not lo be a useful tool to assess the prognosis ofan
individual malignant pheochromocytoma. (Henry Ford Hosp Med J 1989:37:185-6)

H

istology fails to show substantial differences between
clinically benign and malignant adrenomedullary tumors,
and criteria indicative of invasion and malignancy are an unreliable guide to the future outcome of the case (1-3). The only
absolute criterion for diagnosing a malignant pheochromocytoma is the presence of secondary tumor deposits in sites where
chromaffinfissueis not found normally (1,4).
Cytophotometric DNA measurements have been shown to be
a useful auxiliary method in a variety of malignant tumors of
different sites (5-8). DNA data on pheochromocytomas reported
thus far are sparse (4,9-11). Since these reports show discrepant
results regarding the diagnostic and prognostic value of this
method, we perfonned DNA cytophotometry on 50 adrenalectomy specimens belonging to different types of medullary
disease.

mode on a LEITZ-MPV-cytophotometer based on a LEITZOrthoplan microscope. The measuring spot was 2.54 ixm^, and
the steps of the scanning process were 0.5 |xm wide. Absorption
ofthe probes was determined at a wavelength of 560 ± 9.5 nm.
Seventy cells were examined for each case. Data were processed
on-line by a EUROCOS-computer using specially adapted commercial software (LEtTZ, Hamburg, West Germany). Determination of diploid values was performed using normal adrenomedullary cells of the three control specimens; the mean ± 2
standard deviations of their cellular DNA content was defined as
diploid region. Interpretation of the data was perfonned using
the evaluation scheme of Auer et al (5), classifying DNA distribufions into four different histogram types (types I through
IV).

Results
Material and Methods
The 50 adrenalectomy specimens were gathered from the surgical pathology files of different institutes and departments of
pathology. For documentation of preoperative symptoms,
clinical case histories were reviewed. Follow-up data for 25 patients were obtained for an average of 33 months (range I to 180
months).
For reclassification, the hematoxylin-eosin stained slides
were used roufinely. For diagnosis of adrenomedullary hyperplasia, morphometrical analyses of total medullary volumes
were performed as described elsewhere (12). In six nonfunctioning adrenal tumors, the diagnosis of pheochromocytoma depended on the immunocytochemical demonstration of synaptophysin-positivity (13) and negativity forthe adrenocortical
marker Dit (14),
For cytophotometric detennination of DNA content, 6 p,mthick paraffin sections were stained by Schiff's reagent (15). Single cell DNA measurements were performed in the scanning

Henry Ford Hosp Med J—Vol 37. Nos 3 & 4. 1989

Patients' ages at diagnosis ranged from 12 to 78 (mean 47)
years. The male;female ratio was 1:0.96.
The series of 50 adrenalectomy specimens included three normal controls, four cases of adrenomedullary hyperplasia, and 43
pheochromocytomas. Of the 27 sporadic tumors, 22 cases
lacked morphologic or clinical features of malignancy. In 15 of
these patients, follow-up data were available, each showing no
evidence of disease at the end of the observation period. Five
sporadic pheochromocytomas followed a malignant clinical
course. Three of these five patients died two to 13 months after
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surgery; the remaining two still have distant metastases. Sixteen
tumors were neoplasms inherited in the setting of multiple endocrine neoplasia type 2A. Four of these 12 patients had bilateral
disease.
Upon cytophotometry, the adrenal medulla of the three control specimens was characterized by single distinct modal DNA
values in the diploid region of normal cells (type I). The same
finding was obtained for one of the four cases of adrenomedullary hyperplasia, with the remaining three cases exhibiting euploid type II histograms defined as having either a distinct modal
value in the tetraploid or near-tetraploid region or showing two
well defined peaks around the diploid and tetraploid regions.
Two (9%) of the 22 benign sporadic pheochromocytomas also
represented type II histograms. For ten lesions (45.5%), type til
populations were demonstrated, defined as having two pieaks but
differing from the type II populations in that the histograms
showed a sizable number of celts with DNA amounts similar to
those of control celts in DNA synthesis. The positions of the two
peaks, as a rule, deviated somewhat from the diploid and
tetraploid values of normal populations. In ten cases (45.5%),
type IV specimens were seen with a very pronounced and irregular aneuploidy, with DNA amounts per cell ranging from levels
near 2c up to values beyond 6c or even 14c. Ofthefiveclinically
malignant pheochromocytomas, one showed type III and three
exhibited type IV histograms. Among the 16 hereditary pheochromocytomas, types II, III, and IV histograms were found in
three (19%), six (37%), and seven (44%) cases, respectively.
DNA histograms thus did not show consistent differences
when comparing sporadic to hereditary and benign to malignant
pheochromocytomas.

Discussion
To our knowledge, four studies on the diagnostic and prognostic value of DNA determinations in pheochromocytomas
have been reported. In a cytophotometric investigation, Lewis
(9) found benign behavior in each of 12 lesions of diploid DNA
content, whereas distant metastases were demonstrated for each
of three aneuploid pheochromocytomas. Lewis suggested that
such measurements allow discrimination between metastasizing
and benign pheochromocytomas. A similar conclusion was
drawn by Hosaka et al (It) based on flow cytometric studies of
62 pheochromocytomas using the technique of Hedley et al (16).
Each ofthe 18 pafients with normal DNA histograms followed a
benign clinical course, whereas eight of 26 patients classified as
DNA tetraploid/polyploid and seven of 18 patients exhibiting
DNA aneuploid peaks had evidence of malignancy; the differences between these groups were statistically significant.
DNA ploidy measurements thus seemed to provide useful prognostic information, while a clear-cut discrimination of benign
and malignant neoplasms was not possible by this method.
Klein et at (10) estimated flow cytometric DNA determinations
to be an accurate, objective means of identifying adrenal malignancy. However, only one clinically benign euploid pheochromocytoma was included in their study of four normal and
seven neoplasfic adrenal tissues.
At variance to these studies, Amberson et al (4) in recent flow
cytometric investigations found aneuploidy to be a phenomenon
frequently encountered in benign adrenal pheochromocytomas.
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Of 19 such tumors, only six were diploid and nine clearly exhibited aneuploid DNA content.
We found nondiploid DNA values in 38 (88%) of 43 pheochromocytomas, 21 of which clearly exhibited pronounced
aneuploidy. Clinically malignant behavior could be established
in only five of these tumors. The remaining 33 nondiploid lesions lacked morphologic evidence of malignancy, and followup studies in 20 disclosed an uneventful postoperative course.
Based on our results, DNA measurements appear to supply
neither diagnostic nor prognostic information. In addition,
DNA data do not provide differentiation between sporadic and
hereditary tumors. A continuing search is necessary to find
other procedures which provide a clear discrimination of risk
groups in pheochromocytoma patients.
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